What is Galecto Inc.'s earnings per share (EPS)?

Galecto Inc. (GLTO) reported diluted earnings per share of $-18.53 for fiscal year 2024. This represents a 48.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Galecto Inc. Financials

GLTO

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Galecto Inc. (GLTO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

2/9

Galecto Inc. passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.87x

For every $1 of reported earnings, Galecto Inc. generates $0.87 in operating cash flow (-$18.6M OCF vs -$21.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-26.4x

Galecto Inc. earns $-26.4 in operating income for every $1 of interest expense (-$22.3M vs $844K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$22.2M

YoY+43.9%

Galecto Inc.'s EBITDA was -$22.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 43.9% from the prior year.

Net Income

-$21.4M

YoY+44.1%

Galecto Inc. reported -$21.4M in net income in fiscal year 2024. This represents an increase of 44.1% from the prior year.

EPS (Diluted)

$-18.53

YoY+48.6%

Galecto Inc. earned $-18.53 per diluted share (EPS) in fiscal year 2024. This represents an increase of 48.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$14.2M

YoY-34.0%

5Y CAGR+4.6%

Galecto Inc. held $14.2M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+21.4%

Galecto Inc. had 1M shares outstanding in fiscal year 2024. This represents an increase of 21.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-135.4%

YoY-16.8pp

Galecto Inc.'s ROE was -135.4% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 16.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$6.4M

YoY-73.1%

5Y CAGR-20.2%

Galecto Inc. invested $6.4M in research and development in fiscal year 2024. This represents a decrease of 73.1% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

GLTO Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$6.4M-73.1%	$23.8M-50.7%	$48.2M+25.2%	$38.5M+56.3%	$24.6M+24.8%	$19.7M
SG&A Expenses	$10.5M-17.2%	$12.7M-2.4%	$13.0M-5.4%	$13.7M+52.5%	$9.0M+268.5%	$2.4M
Operating Income	-$22.3M+44.2%	-$39.9M+34.8%	-$61.2M-17.2%	-$52.2M-55.3%	-$33.6M-186.3%	$39.0M
Interest Expense	$844K-50.0%	$1.7M+133.9%	$722K+362.8%	$156K	N/A	N/A
Income Tax	$41K	$0	$0	$0	$0	$0
Net Income	-$21.4M+44.1%	-$38.3M+37.8%	-$61.6M-19.1%	-$51.8M-48.6%	-$34.8M+4.6%	-$36.5M
EPS (Diluted)	$-18.53+48.6%	$-36.08	$-2.43-18.5%	$-2.05	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1.4M-3.3%	$1.5M+116.1%	$678K	N/A	$1.1M-40.4%	$1.8M-25.5%	$2.5M	N/A
SG&A Expenses	$1.7M-11.0%	$2.0M+1.8%	$1.9M	N/A	$2.7M-1.0%	$2.8M-15.3%	$3.3M	N/A
Operating Income	-$3.2M+7.7%	-$3.4M-31.6%	-$2.6M	N/A	-$3.8M+31.1%	-$5.6M+2.9%	-$5.7M	N/A
Interest Expense	$42K-16.0%	$50K-32.4%	$74K	N/A	$146K-31.5%	$213K-17.1%	$257K	N/A
Income Tax	$0-100.0%	$4K+100.0%	$2K	N/A	$7K-83.3%	$42K	N/A	N/A
Net Income	-$3.1M+8.8%	-$3.4M-35.7%	-$2.5M	N/A	-$3.9M+27.3%	-$5.3M+2.5%	-$5.5M	N/A
EPS (Diluted)	$-2.36+9.2%	$-2.60-35.4%	$-1.92	N/A	$-3.39	$-4.92+2.6%	$-5.05	N/A

GLTO Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$17.1M-55.2%	$38.2M-47.8%	$73.2M-40.1%	$122.2M-28.8%	$171.6M+203.1%	$56.6M
Current Assets	$16.8M-54.2%	$36.8M-42.5%	$63.9M-42.0%	$110.1M-35.0%	$169.3M+201.9%	$56.1M
Cash & Equivalents	$14.2M-34.0%	$21.5M-34.5%	$32.8M-47.6%	$62.6M-61.8%	$163.6M+1348.4%	$11.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.3M-77.9%	$5.9M-48.4%	$11.4M+129.1%	$5.0M-18.3%	$6.1M-95.2%	$127.8M
Current Liabilities	$1.2M-79.5%	$5.8M-47.5%	$11.1M+144.4%	$4.5M-18.4%	$5.6M-29.8%	$7.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$15.8M-51.0%	$32.3M-47.6%	$61.8M-47.3%	$117.2M-29.2%	$165.5M+332.6%	-$71.1M
Retained Earnings	-$277.5M-8.4%	-$256.1M-17.6%	-$217.7M-39.5%	-$156.1M-49.6%	-$104.4M-50.1%	-$69.5M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$10.7M-21.6%	$13.7M-10.9%	$15.4M-10.3%	$17.1M-26.7%	$23.4M-14.4%	$27.3M-15.9%	$32.5M-15.0%	$38.2M
Current Assets	$9.8M-24.9%	$13.0M-12.7%	$14.9M-11.4%	$16.8M-20.5%	$21.2M-15.9%	$25.2M-17.6%	$30.5M-16.9%	$36.8M
Cash & Equivalents	$7.6M-25.5%	$10.2M-14.5%	$11.9M-15.8%	$14.2M-28.0%	$19.7M-13.9%	$22.9M+8.4%	$21.1M-1.7%	$21.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7M-0.3%	$2.7M+65.3%	$1.7M+27.3%	$1.3M-46.7%	$2.4M-34.2%	$3.7M-14.1%	$4.3M-26.8%	$5.9M
Current Liabilities	$2.6M-0.2%	$2.6M+69.5%	$1.6M+29.6%	$1.2M-51.0%	$2.4M-34.2%	$3.7M-14.1%	$4.3M-25.9%	$5.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$8.0M-26.9%	$11.0M-20.1%	$13.7M-13.4%	$15.8M-24.4%	$20.9M-11.2%	$23.6M-16.2%	$28.2M-12.9%	$32.3M
Retained Earnings	-$286.6M-1.1%	-$283.5M-1.2%	-$280.1M-0.9%	-$277.5M-2.5%	-$270.8M-1.5%	-$266.9M-2.0%	-$261.6M-2.1%	-$256.1M

GLTO Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$18.6M+49.5%	-$36.9M+14.0%	-$42.9M+17.9%	-$52.3M-36.9%	-$38.2M-97.7%	-$19.3M
Capital Expenditures	N/A	N/A	$196K-12.1%	$223K	N/A	N/A
Free Cash Flow	N/A	N/A	-$43.1M+17.9%	-$52.5M	N/A	N/A
Investing Cash Flow	$11.7M-47.8%	$22.3M+80.3%	$12.4M+125.8%	-$48.0M	N/A	-$326K
Financing Cash Flow	N/A	$2.9M+467.3%	$507K	N/A	$187.4M	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$2.6M-16.9%	-$2.2M+8.3%	-$2.4M+50.6%	-$4.9M-35.2%	-$3.7M+11.0%	-$4.1M+30.9%	-$5.9M+48.3%	-$11.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	$0	$0-100.0%	$6.0M+6.2%	$5.7M-41.0%	$9.6M
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GLTO Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-135.4%-16.8pp	-118.6%-18.8pp	-99.8%-55.6pp	-44.1%-23.1pp	-21.1%	N/A
Return on Assets	-125.1%-24.8pp	-100.3%-16.1pp	-84.2%-41.9pp	-42.4%-22.0pp	-20.3%+44.2pp	-64.5%
Current Ratio	14.07+7.8	6.31+0.6	5.75-18.5	24.23-6.2	30.42+23.3	7.07
Debt-to-Equity	0.08-0.1	0.180.0	0.19+0.1	0.040.0	0.04+1.8	-1.80
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-39.1%-7.7pp	-31.4%-12.9pp	-18.5%	N/A	-18.6%+4.1pp	-22.6%-3.2pp	-19.4%	N/A
Return on Assets	-29.2%-4.1pp	-25.1%-8.6pp	-16.5%	N/A	-16.6%+2.9pp	-19.6%-2.7pp	-16.9%	N/A
Current Ratio	3.73-1.2	4.96-4.7	9.62-4.4	14.07+5.4	8.68+1.9	6.79-0.3	7.07+0.8	6.31
Debt-to-Equity	0.34+0.1	0.25+0.1	0.12+0.0	0.08-0.0	0.12-0.0	0.160.0	0.15-0.0	0.18
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Silexion Therapeutics Corp SLXN

$4.0M

Qualigen Therapeutics Inc QLGN

$6.5M

Entero Therapeutics ENTO

$10.1M

THERIVA BIOLOGICS INC TOVX

$10.6M

Biodexa Pharmaceuticals plc BDRX

$2.8M

Frequently Asked Questions

Is Galecto Inc. profitable?

No, Galecto Inc. (GLTO) reported a net income of -$21.4M in fiscal year 2024.

What is Galecto Inc.'s EBITDA?

Galecto Inc. (GLTO) had EBITDA of -$22.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Galecto Inc.'s return on equity (ROE)?

Galecto Inc. (GLTO) has a return on equity of -135.4% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Galecto Inc.'s operating cash flow?

Galecto Inc. (GLTO) generated -$18.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Galecto Inc.'s total assets?

Galecto Inc. (GLTO) had $17.1M in total assets as of fiscal year 2024, including both current and long-term assets.

How much does Galecto Inc. spend on research and development?

Galecto Inc. (GLTO) invested $6.4M in research and development during fiscal year 2024.

How many shares does Galecto Inc. have outstanding?

Galecto Inc. (GLTO) had 1M shares outstanding as of fiscal year 2024.

What is Galecto Inc.'s current ratio?

Galecto Inc. (GLTO) had a current ratio of 14.07 as of fiscal year 2024, which is generally considered healthy.

What is Galecto Inc.'s debt-to-equity ratio?

Galecto Inc. (GLTO) had a debt-to-equity ratio of 0.08 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Galecto Inc.'s return on assets (ROA)?

Galecto Inc. (GLTO) had a return on assets of -125.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Galecto Inc.'s cash runway?

Based on fiscal year 2024 data, Galecto Inc. (GLTO) had $14.2M in cash against an annual operating cash burn of $18.6M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Galecto Inc.'s Piotroski F-Score?

Galecto Inc. (GLTO) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Galecto Inc.'s earnings high quality?

Galecto Inc. (GLTO) has an earnings quality ratio of 0.87x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Galecto Inc. cover its interest payments?

Galecto Inc. (GLTO) has an interest coverage ratio of -26.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.